ClearCure Biosciences
ClearCure Biosciences is a clinical-stage biopharmaceutical company focused on developing non-toxic, first-in-class and best-in-class therapies for cancer, infectious diseases, sepsis, neurological diseases, and cardiovascular conditions. The company emphasizes drugging challenging targets, leveraging proprietary small molecules, nanotechnology, new oncology cell therapies, new transdermal drug delivery technology, AI and omics-driven approaches, and digital health solutions to address serious unmet medical needs. The company is currently seeking collaborators and partnerships.
Industries
N/A
Nr. of Employees
small (1-50)
ClearCure Biosciences
24 5th Avenue Unit 1627 New York, New York 10011
ClearCure Biosciences is currently seeking investment
ClearCure Biosciences is seeking a pre-seed investment in the range of 1m-5m
Products
Novel small molecule therapeutics (pipeline)
Pipeline includes a range of small molecule drugs and new molecular entities for transforming previously untreatable diseases into curable or preventable conditions. The first product to market is a non-toxic intravenous therapy for sepsis.
Novel small molecule therapeutics (pipeline)
Pipeline includes a range of small molecule drugs and new molecular entities for transforming previously untreatable diseases into curable or preventable conditions. The first product to market is a non-toxic intravenous therapy for sepsis.
Expertise Areas
- Oncology therapeutics
- Infectious disease treatment
- Sepsis and septic shock intervention
- Neuroscience drug development
Key Technologies
- Small molecule therapeutics
- Targeted protein modulation
- Cell-based therapy
- Nanotechnology-based delivery
Key People
Founder, CEO
Chief Medical Officer
Medical Advisor and Key opinion Leader
Chief FDA Compliance Officer
Founder, CEO
Chief Medical Officer
Medical Advisor and Key opinion Leader
Chief FDA Compliance Officer